another SP bashing - wonder how long the FDA review will take...

another SP bashing - wonder how long the FDA review will take and what further progress there has been, if at all, on those other items. Management please advise us where its all at???.

may only be clutching at straws here as there may be other more substantial issues not willing to discuss with SH's as the "other potential products" and any other issues may have been mentioned and one presumes discussed in detail with analysts prior to their changing the target SP in their reports. Well opaqueness will only result in the market making assumptions (bad, good or indifferent) which ultimately feeds into the SP. But I guess with $'s to boot no urgency to respond to SH queries as mentioned by ither posters here.

I guess that no ANN's or taking SH queries until November seems a good idea but reality will tell you it may not be. They say karma catches up to one - and so be it!.